otine is an addictive drug that has broad effects throughout the brain. One site of action is the nucleus of the solitary tract (NTS), where nicotine initiates a stress response and modulates cardiovascular and gastric function through nicotinic acetylcholine receptors (nAChRs). Catecholamine (CA) neurons in the NTS influence stress and gastric and cardiovascular reflexes, making them potential mediators of nicotine's effects; however nicotine's effect on these neurons is unknown. Here, we determined nicotine's actions on NTS-CA neurons by use of patch-clamp techniques in brain slices from transgenic mice expressing enhanced green fluorescent protein driven by the tyrosine hydroxylase promoter (TH-EGFP). Picospritzing nicotine both induced a direct inward current and increased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) in NTS-CA neurons, effects blocked by nonselective nAChR antagonists TMPH and MLA. The increase in sEPSC frequency was mimicked by nAChR␣7 agonist AR-R17779 and blocked by nAChR␣7 antagonist MG624. AR-R17779 also increased the firing of TH-EGFP neurons, an effect dependent on glutamate inputs, as it was blocked by the glutamate antagonist NBQX. In contrast, the nicotine-induced current was mimicked by nAChR␣4␤2 agonist RJR2403 and blocked by nAChR␣4␤2 antagonist DH␤E. RJR2403 also increased the firing rate of TH-EGFP neurons independently of glutamate. Finally, both somatodendritic and sEPSC nicotine responses from NTS-CA neurons were larger in nicotine-dependent mice that had under gone spontaneous nicotine withdrawal. These results demonstrate that 1) nicotine activates NTS-CA neurons both directly, by inducing a direct current, and indirectly, by increasing glutamate inputs, and 2) NTS-CA nicotine responsiveness is altered during nicotine withdrawal.
INTRODUCTION
Nicotine is a highly addictive drug that has broad effects in the central nervous system (CNS). It acts at nicotinic acetylcholine receptors (nAChRs), ligand-gated ion channels whose endogenous neurotransmitter is acetylcholine (ACh). In addition to modulating reward, nicotine also stimulates a stress response, modulates cardiovascular and gastric reflexes, inhibits food intake, and reduces body weight (3, 12, 30, 34, 40, 49, 81, 92) , all behaviors and reflexes influenced by neurons in the nucleus of the solitary tract (NTS) in the hindbrain (1, 10, 38, 60, 63, 77, 79, 84, 91, 95) . The peripheral effects of nicotine on the hypothalamic-pituitary-adrenal (HPA) axis are blocked by nAChR antagonists injected into the hindbrain (59) . Moreover, direct injections of nicotine into the NTS modulate cardiovascular (92) , gastric (32) , and stress responses (58) , suggesting that this is a key region for the actions of nicotine.
Vagal afferents carrying homeostatic information from the viscera activate NTS neurons via glutamate release (1, 9, 11, 38, 63, 82) . Nicotine increases vagal afferent discharge and increases the probability of glutamate release from afferent terminals within the NTS (48) . It also induces a postsynaptic current in a subpopulation of NTS neurons (27, 28, 48, 96) . Nicotine has been shown to activate GABAergic NTS neurons (101) , however, the other phenotypes of NTS neurons activated by nicotine are not known.
A 2 /C 2 catecholamine neurons in the NTS (NTS-CA neurons) are important for controlling a variety of functions, as disrupting the activity of NTS-CA neurons affects food intake, cardiovascular reflexes, and reward processing (47, 52, 64, 78, 86) . NTS-CA neurons project to a variety of brain regions, including the hypothalamus, amygdala, nucleus accumbens, and brainstem (70, 74, 75, 79, 84, 91, 93, 98) ; sites at which the release of catecholamines modulates a number of behaviors, including reward, stress, and food intake (14, 54, 88) . NTS-CA involvement in food intake is further supported by a recent study conducted by Roman et al. (80) , which demonstrates that direct projections from NTS-CA neurons to the parabrachial nucleus mediate anorexic behavior elicited by targeted NTS-CA activation. Interestingly, the systemic effects of nicotine on the HPA are blocked both by lesions of hindbrain CA neurons and by antagonism of adrenoreceptors in the hypothalamus (59) , suggesting hindbrain CA neurons to be important mediators of nicotine's actions. Consistent with this hypothesis, injections of nicotine directly into the NTS increases norepinephrine (NE) release in the paraventricular hypothalamus (PVH) and amygdala (103) , and the effect of systemic nicotine to release NE is blocked by nAChR antagonists applied to the fourth ventricle (34) . However, the underlying mechanisms by which nicotine controls the activity of NTS-CA neurons are unknown.
Withdrawal from chronic nicotine causes many aversive symptoms, which significantly contribute to the difficulty in quitting smoking (71) . NTS-CA neurons have been suggested to mediate some of these symptoms (49, 88) . However, the mechanisms involved are not well understood. The goals of this study were to determine 1) the cellular mechanisms by which nicotine activates NTS-CA neurons and 2) how the effects of nicotine are altered during nicotine withdrawal.
MATERIALS AND METHODS
Animal welfare assurances. All animal procedures were conducted with the approval of the Animal Care and Use Committees at Washington State University (WSU) and in accordance with the US Public Health Service Policy on Humane Care and Use of Laboratory Animals (PHS Policy) and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. We understand the ethical principles under which this journal operates and that our work complies with this animal ethics checklist.
Horizontal NTS slice preparation. A total of 128 transgenic mice, both male and female, 8 -16 wk of age, weighing 20 -30 g, were used in all experiments. All mice expressed enhanced green fluorescent protein under the control of the tyrosine hydroxylase promoter (TH-EGFP) (56) and were maintained on a C57BL/6J (Jackson Laboratory) background. TH-EGFP mice were bred at WSU and allowed ad libitum access to food and water. Mice were anesthetized by inhalation of isoflurane gas (2-4%) and euthanized by thoracic compression (pneumothorax) as previously described (22, 68) . The hindbrain was removed and placed for 1 min in cold (0 -4°C) artificial cerebrospinal fluid (aCSF) composed of the following (in mM): 125 NaCl, 3 KCl, 1.2 KH2PO4, 1.2 MgSO4, 25 NaHCO3, 10 dextrose, 2 CaCl2, and bubbled with 95% O2-5% CO2 (pH 7.4, 306 -310 mosM adjusted with sucrose). The medulla was trimmed to a 1-cm block (rostral-caudal) centered on the obex. The tissue block was mounted in a vibrating microtome (Leica VT-1000S). Horizontal slices (250 m thick) were cut with a sapphire knife (Delaware Diamond Knives, Wilmington, DE), submerged in a microscope chamber, and perfused with oxygenated aCSF at a rate of 2 ml/min (2, 15) .
Electrophysiology. TH-EGFP neurons from the caudal NTS were visually selected for electrophysiological patch-clamp recordings using a fluorescence microscope (Olympus BX51WI). Neurons were recorded from the NTS within 200 m from obex and medial to the solitary tract (ST). Patch electrodes were guided to neurons by use of differential interference contrast (DIC) optics illuminated with infrared light. Voltage-clamp and current-clamp recordings were made with a MultiClamp 700B amplifier, Digidata 1440A digitizer, and pClamp10.2 software (all from Molecular Devices, Sunnyvale, CA). Data were filtered at 10 kHz and stored on a personal computer for offline analysis. For recordings, patch pipettes were pulled using a pipette puller (P-2000; Sutter Instruments, Novato, CA). The pipette resistance was 3.0 -4.0 M⍀ when filled with internal solution (in mM: 10 NaCl, 130 K gluconate, 11 EGTA, 1 CaCl2, 2 MgCl2, 10 HEPES, 2 Na-ATP, 0.2 Na-GTP, pH 7.3, 297-300 mosM). After formation of a stable giga-ohm seal (Ͼ2 G⍀), the whole cell configuration was established. Cells were held at Ϫ60mV for all voltage-clamp experiments. Only neurons with holding currents not exceeding Ϫ100 pA at Ϫ60 mV for the 15-min control period (membrane resistance Ͼ250 M⍀) were studied further. Series resistance (Ra) was measured at the beginning and end of recordings, and neurons were not included in additional analysis if it exceeded 20 M⍀.
aCSF was heated to 32 Ϯ 0.5°C using a preheater, a temperature sensor positioned on the wall of the recording chamber next to the slice, and a temperature controller (Cell Micro Controls, Norfolk, VA). No statistical differences in nicotine responses were apparent on the basis of animal sex; therefore, the two groups were combined. Nicotinic agonists were applied every 20 min via picospritzer pipettes (application pressure 2 psi; 0.5-s duration; Parker Hannifin, Cleveland, OH) with resistance 1-1.5 M⍀. The tip of the application pipette was positioned~35 m from the recorded neuron. Each recorded neuron was exposed to only one concentration of agonist. Selective nicotinic antagonists were applied to the extracellular bath solution after establishment of a nicotine response in control aCSF. The extracellular solution was identical to the oxygenated aCSF that was used for the brain tissue preparation.
Miniature excitatory postsynaptic currents (mEPSC) were isolated by adding the voltage-dependent sodium channel blocker tetrodotoxin (TTX, 0.5 M) to the perfusion solution, and cells were recorded at a holding potential of Ϫ60 mV. To study excitatory nicotine responses in the absence of ␥-aminobutyric acid A (GABAA) and N-methyl-Daspartate (NMDA)-type glutamate receptor currents, GABAA receptor antagonist GABAzine (10 M), and the NMDA receptor antagonist APV (100 M) were included in the bath solution during the nicotine puff application at a holding potential of Ϫ60 mV. Chronic nicotine treatment. TH-EGFP mice were implanted with osmotic minipumps (model 2004, Alzet). Mice were anesthetized with isoflurane, and minipumps were implanted subcutaneously between the shoulder blades; the scalpel wound was then closed with wound clips and treated with topical antibiotic. Animals were administered ketoprofen analgesic (3-5 mg/kg im) once after surgery and repeated if necessary. Pumps delivered nicotine at a rate of 24 mg·kg Ϫ1 ·day Ϫ1 (57) . Implanted mice were split into "chronic" and "withdrawn" treatment groups. Mice in the chronic group were euthanized 14 days after pump insertion, and brain slices were prepared for patch-clamp recording. Mice in the withdrawn group were also treated for 14 days, with the addition of minor surgery performed to remove the pump 24 h before being euthanized. Previous studies have shown that behavioral signs of spontaneous nicotine withdrawal are evident 24 h after removal of the osmotic pump (19, 24, 50) . For this study, the experimenter was blind to the contents of the pump, i.e., did not know whether the mice had been exposed to saline or nicotine for both the recordings and the data analysis. Neurons positive for EGFP were recorded in whole cell patch clamp.
Data analysis. The mean frequency of sEPSCs (Hz), basal firing rate (Hz), and amplitude of inward current (pA), were analyzed using Mini Analysis 6.0.3 (Synaptosoft, Decatur GA), and Clampfit 10.2 (Molecular Devices, Sunnyvale, CA) software. sEPSC responses to nicotine were assessed by comparing the mean baseline sEPSC frequency (15 s immediately before nicotine puff) to the mean frequency during the nicotine response (analyzed over a 15-s period starting 10 s after onset of the puff). All data are presented as means Ϯ SE. The level of statistical significance was defined by the P value Ͻ0.05. The statistical significance of drug effects was determined by one-way ANOVA (Student-Newman-Keuls mode), using SigmaStat (SigmaPlot 11.2). For chronic exposure studies, significant differences between treatment groups were determined by one-way ANOVA. minimize desensitization of nAChRs (72), nicotine was applied by picospritzer. The placement of the picospritzer relative to the recorded neuron and its position in the slice are shown in Fig. 1A . We used TH-EGFP mice to identify catecholamine neurons in the NTS, as we have previously demonstrated that greater than 88% of neurons that express EGFP in this mouse line also express TH in this region of the NTS (15) . Furthermore, 90% of TH-EGFP neurons are directly activated by solitary tract afferents (2, 15) , identifying them as second-order neurons. Picospritzer application of 100, 200, and 300 M nicotine activated an inward current in 45 of 48 TH-EGFP neurons tested ( Fig. 1, D-F) . The effect was concentration dependent (Fig. 1I ). In contrast, puffing aCSF had no effect on the holding current in TH-EGFP neurons (Fig. 1C ; Ϫ0.99 Ϯ 1.81 pA, n ϭ 9).
Nicotine increases the frequency of spontaneous glutamate inputs onto TH-EGFP neurons. Picospritzing 100 -300 M nicotine also increased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) in all 48 TH-EGFP neurons tested. The effects were again concentration dependent ( Both nicotine's induction of a current and increase in sEPSC frequency were reproducible with a second application after a 10-min wash (100.53 Ϯ 0.98% of direct current elicited from first puff, n ϭ 7; 104.58 Ϯ 6.28% of effect on sEPSCs elicited from first puff, n ϭ 5). However, to be conservative, we allowed 20 min before repeating any drug application in both TH-EGFP and non-TH neurons.
Nicotine also increases sEPSC frequency and induces an inward current in non-TH NTS neurons. We next compared the effect of nicotine on non-TH (EGFP-negative) neurons to TH (EGFP-positive) neurons. Nicotine increased sEPSC frequency in non-TH neurons in a concentration-dependent manner ( 19 pA at 400 M (P Ͻ 0.001, n ϭ 6/6) (one-way ANOVA). There were no significant differences in the size of nicotine-induced currents between TH-EGFP and non-TH neurons at any concentration (P Ͼ 0.05, two-way ANOVA).
Nonselective antagonists of nAChRs block nicotine's effects in TH-EGFP neurons. To confirm that the nicotine-induced inward current and increased sEPSC frequency were mediated by nAChRs, we puffed nicotine in the presence of nonselective nAChR antagonists TMPH (66) or MLA (25) . As shown above, picospritzing 200 M nicotine induced an inward current and increased sEPSC frequency (Fig. 2, A and C) . Both of these effects were completely blocked by nonselective antagonists TMPH 300 nM (P Ͻ 0.001, n ϭ 7) and MLA 100 nM (P Ͻ 0.01, n ϭ 6) ( Fig. 2, B and D-F). Application of MLA alone (control 1.872 Ϯ 0.424 vs. MLA 1.363 Ϯ 0.419 Hz, P ϭ 0.41, n ϭ 6) or TMPH alone (control 1.848 Ϯ 0.256 vs. TMPH 2.317 Ϯ 0.530 Hz, P ϭ 0.43, n ϭ 15) had no effect on sEPSC frequency.
DNQX does not block the direct nicotine current. An increase in afferent glutamate release, observed as an increase in sEPSC frequency, can cause a depolarization in NTS neurons. For example, the VR1-R agonist capsaicin depolarizes NTS 
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MODULATION OF NTS-CA NEURONS BY NICOTINE neurons through a presynaptic action of increased glutamate release (23) . To confirm that the nicotine-induced inward current was a direct action on TH-EGFP neurons and not due to the increase in spontaneous glutamate inputs, we puffed on nicotine in the presence of the selective non-NMDA glutamate receptor antagonist DNQX (46) . The amplitude of the nicotineinduced current was not altered by bath-applied DNQX (30 M, n ϭ 8; Fig. 3, B and D) . In contrast, DNQX completely blocked glutamatergic sEPSCs and, therefore, any indirect effects of nicotine on TH-EGFP neurons through increased glutamate release (30 M, P Ͻ 0.001, n ϭ 8, one-way ANOVA).
Nicotine increases the action potential firing rate of TH-EGFP neurons. We next wanted to determine whether nicotine depolarized NTS TH-EGFP neurons and whether this altered their action potential (AP) firing rate. The resting membrane potential (V m ) of TH-EGFP neurons was between Ϫ62 and Ϫ68 mV (n ϭ 34) in current-clamp; 200 M nicotine depolarized all TH-EGFP neurons tested, an average of 17.84 Ϯ 1.34 mV (P Ͻ 0.001, n ϭ 8). When nicotine caused only a small depolarization (4.47 Ϯ 1.54 mV, n ϭ 3), it increased AP firing from a spontaneous rate of 0.24 Ϯ 0.03 Hz to 2.85 Ϯ 0.08 Hz (P Ͻ 0.001, n ϭ 3/8; Fig. 3E ). In contrast, when nicotine induced a large depolarization, neurons displayed a burst of rapid AP firing, followed by a period of quiescence, presumably because the large depolarization resulted in voltage-gated Na ϩ channel inactivation. The non-NMDA ionotropic glutamate receptor antagonist NBQX [25 M (35) ] did not block the nicotine-induced depolarization or the increase in firing rate (n ϭ 8; Fig. 3F ), suggesting that the direct somatodendritic action of nicotine is sufficient to excite TH-EGFP neurons at the level of AP generation.
nAChR␣7 antagonist blocks the effect of nicotine on sEPSC frequency in TH-EGFP neurons. To determine which receptor subtype mediates the effects of nicotine, we tested whether an ␣7-subunit-containing nicotinic receptor (nAChR␣7) antagonist MG624 (37) blocked the effect of nicotine on sEPSC frequency. The nicotine-induced increase in sEPSC frequency was completely blocked by bath application of 1 M MG624 (n ϭ 7; Fig. 4, B and C) . In contrast, MG624 had no effect on the nicotine-induced inward current (P ϭ 0.517, n ϭ 7; Fig. 4 , B and D). (39) , significantly increased the frequency of sEPSCs (1.4 Ϯ 0.13 vs. 5.06 Ϯ 1.26 Hz, P ϭ 0.017, n ϭ 6; Fig. 5, A and B) in TH-EGFP neurons without affecting sEPSC amplitude (Ϫ62.91 Ϯ 2.86 vs. Ϫ62.29 Ϯ 2.25 pA, P ϭ 0.87, n ϭ 6). In contrast, it did not induce an inward current. AR-R17779 at 200 M also significantly increased the AP firing rate in TH-EGFP neurons (559.81 Ϯ 176.92% of control, P Ͻ 0.001, n ϭ 5; Fig. 5C ).
However, AR-R17779 did not induce any depolarization, and its effects on AP firing were completely abolished by bath application of the AMPA/Kainate glutamate receptor antagonist NBQX (25 M) (26.62 Ϯ 16.41% of AR-R17779 alone, n ϭ 5; Fig. 5 , D and E). We (15) have previously shown that some NTS-CA neurons fire spontaneously and that when they do, NBQX reduces the rate of firing, consistent with spontaneous glutamate inputs impacting firing. In low-spiking NTS-CA neurons, NBQX does not alter basal firing rate but blocks the ability of other excitatory presynaptic neurotransmitters, such as serotonin, to increase firing (17) . For the present study, to easily detect an increase in firing, we selected neurons that were firing at a relatively lower frequency under control conditions but that were still firing spontaneously (0.241 Ϯ 0.025 Hz, n ϭ 5). NBQX blocked the effect of AR-R17779 to increase firing, suggesting that the effect on firing resulted from an increase in "spontaneous" glutamate release. Since nAChRs rapidly desensitize, we waited 20 min between consecutive applications of AR-R17779, as the effects of AR-R17779 were reproducible after this time (462.26 Ϯ 40.19% of control for first application, and 456.14 Ϯ 118.13% of control for a second application, P ϭ 0.953, n ϭ 7; Fig. 5E ).
To further examine whether this effect occurs through a presynaptic mechanism, we puffed 200 M AR-R17779 onto NTS-CA neurons during bath application of TTX to block sodium channels and isolate miniature excitatory postsynaptic currents (mEPSCs). In the presence of 0.5 M TTX, picospritzer application of 200 M AR-R17779 increased the frequency of mEPSCs (1.316 Ϯ 0.197 vs. 3.762 Ϯ 0.456 Hz, P Ͻ 0.001, n ϭ 20, one-way ANOVA; Fig. 5F ), with no change in amplitude (Ϫ45.17 Ϯ 2.541 vs. Ϫ43.44 Ϯ 2.627 pA, P ϭ 0.639, n ϭ 20, one-way ANOVA). These data indicate that AR-R17779's action at nAChR␣7 is still seen on mEPSCs as well as sEPSCs, consistent with a presynaptic mechanism of action. Taken together, these results suggest that the nicotine-induced increase in sEPSC frequency is mediated by presynaptic nAChR␣7s increasing glutamate release.
nAChR␣4␤2 antagonist blocks the direct nicotine current in TH-EGFP neurons. To determine which nAChR subtype mediated the inward current, we examined the effect of DH␤E, a competitive nAChR antagonist with moderate selectivity for neuronal nAChRs containing ␣4␤2 subunits (99) . Bath application of 100 M DH␤E greatly reduced the nicotine-induced inward current(P Ͻ 0.01, n ϭ 5; Fig. 6, B and D) . In contrast, 100 M DH␤E had no effect on nicotine's ability to increase the frequency of sEPSCs (P ϭ 0.538, n ϭ 6, one-way ANOVA; Fig. 6C ).
nAChR␣4␤2 agonist mimics the nicotine-induced current in TH-EGFP neurons. To confirm the role of nAChR␣4␤2, we determined whether RJR2403, a selective neuronal nicotinic ␣4␤2 receptor agonist (7) , would mimic the effect of nicotine to induce a direct inward current. In voltage-clamp mode, a puff of 200 M RJR2403 activated an inward current in TH-EGFP neurons (Ϫ188.52 Ϯ 88.49 pA, P Ͻ 0.05, n ϭ 12; Fig. 7, A and B) . In contrast, there was no significant change in sEPSC frequency (101.12 Ϯ 5.88% of control, P ϭ 0.938, n ϭ 12; Fig. 7, A and B) . Puffing on 200 M RJR2403 also induced a depolarization (15.37 Ϯ 2.73 mV, P Ͻ 0.002, n ϭ 14) and increased the firing rate of APs in TH-EGFP neurons to 1,040.85 Ϯ 328.09% of control (P Ͻ 0.002, n ϭ 14; Fig. 7 , C Note that, in the absence of NBQX, the second application of AR-R17779 (Re/AR-R) was not significantly different from the first after a 20-min wash (P ϭ 0.953, n ϭ 7, one-way ANOVA). F: average frequency of miniature EPSCs before and after AR-R17779 application (*P Ͻ 0.001, n ϭ 20, one-way ANOVA).
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Excitatory nicotine responses in TH-EGFP neurons are not affected by blockade of GABA A or NMDA receptors. To confirm that neither GABA A nor NMDA receptors were involved in nicotine-induced excitatory responses, we delivered puffs of 200 M nicotine onto TH-EGFP neurons in the presence of both the GABA A receptor antagonist GABAzine (10 M), and the NMDA receptor antagonist APV (100 M). The amplitude of nicotine-induced inward currents was unchanged during bath application of APV ϩ GABAzine (aCSF ϭ Ϫ300.65 Ϯ 72.37 vs. GABAzineϩAPV ϭ Ϫ338.22 Ϯ 129.75 pA, P ϭ 0.802, n ϭ 15). Likewise, APV ϩ GABAzine did not significantly alter the frequency (6.19 Ϯ 0.68 vs. 6.13 Ϯ 0.47 Hz, P ϭ 0.95, n ϭ 17, 21) or amplitude (Ϫ52.28 Ϯ 5.5 vs.
Ϫ46.42 Ϯ 4.23 pA, P ϭ 0.39, n ϭ 17,21) of sEPSCs following nicotine application. On the basis of these data, we conclude that GABA A and NMDA receptors do not play a major role in mediating direct or indirect excitatory nicotine responses in NTS TH-EGFP neurons.
Nicotine responses from TH-EGFP neurons are enhanced during spontaneous nicotine withdrawal. We next determined whether the effects of nicotine are altered following chronic exposure. TH-EGFP mice were treated for 14 days with either nicotine (24 mg·kg Ϫ1 ·day Ϫ1 ) or saline via osmotic minipump and were euthanized either immediately after chronic treatment or 24 h after pump removal (spontaneous withdrawal). TH-EGFP neurons were recorded in voltage-clamp, and the response to a puff of nicotine (200 M) was determined. The average amplitude of direct nicotine currents recorded in chronic nicotine-treated animals was not statistically different from that of control animals that received chronic saline (Ϫ364.01 Ϯ 59.55 vs. Ϫ288.39 Ϯ 69.39 pA, P ϭ 0.43, n ϭ 26; Fig. 8A ). Likewise, nicotine-induced increases in sEPSC frequency did not differ significantly between chronic nicotinetreated animals and saline controls (128.59 Ϯ 33.28 vs. 100.51 Ϯ 28.24% increase from baseline, P ϭ 0.62, n ϭ 31; Fig. 8B ). However, direct nicotine currents in mice undergoing spontaneous withdrawal (Withdrawn NIC) were significantly larger than those of pump-removal controls (Ϫ320.52 Ϯ 67.45 vs. Ϫ945.33 Ϯ 158.46 pA, P Ͻ 0.001, n ϭ 22; Fig. 8A ). The effect of nicotine to increase sEPSC frequency was also enhanced in nicotine withdrawn animals compared with salinetreated animals whose pumps were also removed (118.3 Ϯ 40.98 vs. 523.99 Ϯ 140.01% increase from baseline, P Ͻ 0.001, n ϭ 21; Fig. 8B ).
The baseline sEPSC frequency was not significantly different across any of the treatment groups (Chronic SAL, 2.73 Ϯ 0.38 Hz; Chronic NIC, 2.33 Ϯ 0.41 Hz; Withdrawn SAL, 2.57 Ϯ 0.43 Hz; Withdrawn NIC, 2.13 Ϯ 0.29 Hz; P ϭ 0.66, n ϭ 36; Fig. 8C ). The basal firing rate of TH-EGFP neurons was also not significantly different across the treatment groups (Chronic SAL, 3.01 Ϯ 0.41 Hz; Chronic NIC, 2.98 Ϯ 0.45 Hz; Withdrawn SAL, 3.33 Ϯ 0.72 Hz; Withdrawn NIC, 2.79 Ϯ 0.52 Hz; P ϭ 0.67, n ϭ 42; Fig. 8D ). 
DISCUSSION
Nicotine acts in the NTS to affect cardiovascular function, HPA activity, and reward (21, 49, 58, 92, 103) , and some aversive aspects of nicotine withdrawal are proposed to be mediated by NTS-CA neurons (33, 88) . Little is known about the cellular mechanisms by which nicotine activates NTS-CA neurons. Here, we report four new findings. 1) Nicotine activates an inward current in NTS-CA neurons by activating nAChR␣4␤2; 2) nicotine increases the frequency of glutamate inputs onto NTS-CA neurons by activating nAChR␣7; 3) nicotine increases the firing rate of NTS-CA neurons through both direct and indirect mechanisms; and 4) both effects of nicotine are larger during chronic nicotine withdrawal.
Nicotine activates NTS-CA neurons through direct and indirect mechanisms. Here, we show that NTS-CA neurons are uniformly activated by nicotine, directly, through nAChR␣4␤2, and indirectly, through increased glutamate release via nAChR␣7, presumably through a presynaptic mechanism as the nAChR␣7 agonist AR-R17779 increases mEPSC frequency but not amplitude. Nicotine was previously shown to increase glutamate inputs (48) and induce postsynaptic currents in approximately one-half of NTS neurons through nAChR␣7 and nAChR␣4␤2, respectively (48, 87) , some of which are GABAergic (101) . However, the neurotransmitter phenotype of the other neurons was not known. Interestingly, we found that nicotine has broad effects on non-CA neurons, suggesting a wide influence of nicotine on NTS function. Our response rate is higher than that reported for neurons in the rat NTS (48, 87) , as well as among mouse NTS GABAergic neurons projecting to the dorsal motor nucleus of the vagus (DMNV) (101) . The variance may reflect differences in slice preparation, since we use a horizontal brain slice as opposed to a coronal slice, and may therefore record from slightly different regions of the NTS. Most of our recordings are made within 1-200 m of the caudal end of the fourth ventricle (obex), and this could be a region that is particularly sensitive to nicotine. Nicotine preferentially activates DMNV-projecting NTS neurons compared with those that project to the parabrachial nucleus (27) . NTS-CA neurons have been shown to project to both regions (8, 79, 80) and presumably represent some of the nicotinesensitive neurons in both groups, in addition to the GABA neurons identified by Xu et al. (101) .
Physiological implications for nicotinic activation of NTS-CA neurons. NTS-CA neurons make extensive projections to other nuclei, including the arcuate nucleus of the hypothalamus, the nucleus accumbens, and the DMNV (5, 18, 74, 79, 83, 84, 98) . These projections are proposed to be important for the actions of drugs of abuse (49, 53, 88, 97) , cardiovascular reflexes (47, 52, 86) , and food intake (62, 76, 80, 100) , as well as other homeostatic functions (44, 94) . Nicotine alters all of these behaviors (49) . Given that nicotine activated~96% of NTS-CA neurons tested, our results predict that nicotine will modulate transmitter release at all of these sites, potentially influencing an array of behaviors and functions (1, 10, 38, 53, 78, 79, 84, 91, 97) . In addition to catecholamines, NTS-CA neurons also contain both neuropeptide Y (85) and glutamate (89) , and nicotine could therefore influence the release of all of these neurotransmitters. These actions presumably act in concert with the effects of nicotine on other pathways [e.g., in the hypothalamus (61) and reward 
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Although nicotine has broad effects on NTS neurons, our results show that NTS-CA neurons are especially sensitive to the effects of nicotine on glutamate release. The main sources of glutamate in the NTS are solitary tract afferents carrying information from the periphery, and 90% of NTS-CA neurons are activated by these sensory afferents (2) . However, as the nicotine-induced increase in glutamate release is sufficient to drive the firing of NTS-CA neurons, nicotine could potentially activate NTS neurons independently of vagal firing. This effect to increase glutamatergic inputs onto NTS-CA neurons is similar to the effects of other hormones and neurotransmitters that inhibit food intake, such as cholecystokinin (CCK), serotonin, and oxytocin. However, nicotine is more unusual, as it also has widespread direct postsynaptic actions on NTS neurons. In contrast, CCK, oxytocin, ghrelin, serotonin, and opioids all control NTS neuronal activity indirectly through presynaptic modulation of glutamate release (2, 6, 15-17, 36, 43, 45, 69, 90) . Interestingly, angiotensin II was also recently shown to have postsynaptic actions on NTS neurons (13) , and oxytocin has postsynaptic actions in a subpopulation of NTS neurons (43, 69) .
Chronic nicotine-induced adaptations in NTS-CA neurons. Our observation that mice undergoing nicotine withdrawal exhibit an increased magnitude of both direct and indirect acute nicotine responses suggests that NTS-CA neurons become hypersensitive to nicotine following a 24-h abstinence period and that this is due to increased function in two distinct receptor subtypes. The enhanced nicotine responses we observed in withdrawn animals are consistent with reports of nAChR upregulation occurring as a result of chronic nicotine exposure (20, 67, 102) . While withdrawn and nonwithdrawn nicotine-dependent mice were both treated for 14 days, only withdrawn mice exhibited hypersensitivity. One explanation is that nAChRs become desensitized in nonwithdrawn mice (72) and that this desensitization persists into the recording period, effectively masking the enhanced nicotine response that was observed in withdrawn mice. nAChR upregulation may therefore provide a compensatory mechanism that serves to counteract the desensitization of surface receptors by the prolonged presence of nicotine in the NTS. A sudden abstinence from chronic nicotine might yield a state in which nAChRs are both upregulated and relieved of desensitization, thus increasing the total nAChR current. Interestingly, our results therefore suggest that chronic nicotine induces a form of adaptation in NTS-CA neurons that only becomes evident during withdrawal. Our model of chronic exposure results in brain nicotine levels that are consistent with those of heavy smokers (300 -400 nM) (57), suggesting that this compensation is relevant in people who suddenly abstain from cigarettes.
Endogenous cholinergic signaling. The cholinergic system has been shown to be critical for the control of food intake (4, 42) . Cholinergic fibers are present within the NTS (26, 65) . The proximity of the NTS to the DMNV, which contains many cholinergic neurons, suggests that the DMNV is a possible source of ACh, potentially through volume transmission (55), as has been suggested previously by Kalappa et al. (48) . Alternatively, it has also been reported that choline acetyltransferase (ChAT) and ACh are present in nodose ganglion cell bodies (26) , and removal of the nodose ganglion results in decreased levels of ChAT in the NTS (41) . These reports raise the possibility that vagal afferents are a source of ACh in the NTS and that they function to bolster the activity of glutamatergic terminals of the same origin. Interestingly, we found no evidence of a basal cholinergic tone in our slices, as the antagonists had no effect by themselves. It is possible that we do not preserve tonically active projections in our slice preparation; alternatively, these neurons may not receive tonic inputs, as suggested by the lack of an effect of an intra-NTS injection of a nAChR antagonist on gastric tone in vivo (31) . Instead, cholinergic inputs could be activated under certain conditions. Critical future questions include whether endogenous cholinergic inputs act both pre-and postsynaptically, what activates them, and how chronic nicotine might alter the normal cholinergic input. Our results suggest that, during withdrawal, NTS-CA neurons will also be more sensitive to endogenous cholinergic input, as both nicotine and ACh activate nAChRs. Interestingly, we did not see a change in the baseline frequency of glutamatergic inputs or in the resting AP firing rate in NTS-CA neurons during withdrawal. However, there is no effect of nAChR antagonists in our slice, suggesting that we do not maintain a tonic input from the endogenous cholinergic circuitry as discussed above. If an endogenous cholinergic tone or input were activated in vivo, we would predict that the firing rate of NTS-CA neurons would be greater during withdrawal. NTS-CA neurons are activated, at least at the level of gene transcription, during withdrawal from chronic opioids (53) , and chronic nicotine exposure increases the expression of TH and neuropeptide Y protein (but not mRNA) in the NTS (29) . However, since overactivation of neurons by nicotine can result in an occlusion of neuronal firing, it is possible that these neurons become strongly activated at the level of gene transcription during withdrawal but actually stop firing and therefore presumably no longer release neurotransmitter.
Perspectives and Significance
In summary, our data elucidate two distinct mechanisms by which nicotine can broadly and strongly activate NTS-CA neurons to increase catecholamine release in their target nuclei to influence behaviors such as food intake, motivation, stress, and cardiovascular function. Additionally, our results show that NTS-CA neurons have an increased response to both direct and indirect effects of nicotine during withdrawal, which could impact how both endogenous and exogenous activation of nAChRs controls the activity of these neurons.
